What is BFRI's gross margin?

Biofrontera (BFRI) has a gross margin of 80% and a net margin of -5%.

What is BFRI's P/E ratio?

Track Biofrontera (BFRI) P/E ratio, ROE, and valuation metrics over time.

Where can I see BFRI's full financials?

See Biofrontera (BFRI) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Biofrontera (BFRI) Financials — Revenue, Earnings, Cash Flow

Also trades as: BFRIW (NASDAQ) · $vol 0M

$1.01

-0.03 (-2.40%)

Weekly Expected Move ±12.9%

$1 $1 $1 $1 $1

NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Strong Sell · Power 33 · $13.0M mcap · 11M float · 4.34% daily turnover · Short 37% of daily vol

📊 Key Metrics

TTM

$46M

Revenue

+17.8% YoY

$-6M

Net Income

+61.6% YoY

$-8M

Free Cash Flow

+15.6% YoY

79.9%

Gross Margin

-4.4%

Op. Margin

-5.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-988.4%

ROA-28.8%

ROIC-39.2%

Valuation

P/E-1.7

P/B2.2

EV/EBITDA-2.7

Leverage

Debt/Equity1.26

Current Ratio1.18

Interest Cov.-26.9x

Quality Scores

Piotroski F4/9

Altman Z-6.19

Beneish M1.85